Antibodies,%20Monoclonal
Showing 1 - 25 of 7,894
Medicare Anti-Aß mAb Coverage With Evidence Development Study
Recruiting
- Mild Alzheimer's Disease
- Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease
- Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer's Disease
-
Baltimore, MarylandCenters for Medicare and Medicaid Services
Sep 21, 2023
Covid-19 Convalescent Plasma and Monoclonal Antibodies Treatment
Recruiting
- COVID-19 Convalescent Plasma Treatment
-
Strasbourg, FranceService des Maladies Infectieuses et Tropicales - CHU de Strasbo
Jun 15, 2023
Clostridium Infection Trial in Paris (Collection of peripheral blood mononuclear cells)
Completed
- Clostridium Infection
- Collection of peripheral blood mononuclear cells
-
Paris, FranceMaladies infectieuses et tropicales, Hôpital Pitié-Salpêtrière
Oct 3, 2022
Monoclonal Gammopathy of Uncertain Significance Trial in Utrecht (Zanubrutinib Oral Product)
Not yet recruiting
- Monoclonal Gammopathy of Uncertain Significance
- Zanubrutinib Oral Product
-
Utrecht, NetherlandsUniversity Medical Center Utrecht
Jul 6, 2023
HIV Trial in South Africa (VRC01.23LS, PGT121.414.LS, PGDM1400LS)
Not yet recruiting
- HIV Infections
- VRC01.23LS
- +2 more
-
Cape Town, Western Cape, South Africa
- +7 more
Jul 24, 2023
Headache, Migraine Trial in Chicago, Naperville (Ubrogepant 50 MG [Ubrelvy], Ubrogepant 100 MG [Ubrelvy])
Not yet recruiting
- Headache, Migraine
- Ubrogepant 50 MG [Ubrelvy]
- Ubrogepant 100 MG [Ubrelvy]
-
Chicago, Illinois
- +1 more
Aug 14, 2022
A Real-World Study of Anti-SARS-CoV-2 Monoclonal Antibodies
Recruiting
- Immunocompromised Patients
- Data collection
-
Paris, Ile De France, FranceAssistance Publique - Hôpitaux de Paris (AP-HP) - Cochin Hospita
Jul 5, 2022
Isolation of Human Recombinant Therapeutic Monoclonal
Recruiting
- Pseudomonas Aeruginosa
- Multi-antibiotic Resistance
- Isolation of anti-Pseudomonas antibodies from type B lymphocytes
-
Grenoble, FranceChu Grenoble Alpes
May 6, 2022
Long COVID, Post-Acute Sequela of COVID-19, Post-Acute COVID-19 Trial in San Francisco (AER002, Placebo)
Not yet recruiting
- Long COVID
- +2 more
- AER002
- Placebo
-
San Francisco, CaliforniaUCSF/Zuckerberg San Francisco General Hospital
Jun 2, 2023
Non Small Cell Lung Cancer, Colorectal Cancer, Breast Cancer Trial in Huntersville (FT536, Cyclophosphamide, Fludarabine)
Recruiting
- Non Small Cell Lung Cancer
- +6 more
- FT536
- +10 more
-
Scottsdale, Arizona
- +4 more
Dec 27, 2022
Against BK Virus Infection Based on Monoclonal Antibodies
Not yet recruiting
- BK Virus Infection
-
Strasbourg, FranceService de Virologie - CHU Strasbourg - France
Feb 21, 2022
Allergic Rhinitis, Conjunctivitis Trial (REGN5713, REGN5714, REGN5715)
Not yet recruiting
- Allergic Rhinitis
- Conjunctivitis
- REGN5713
- +3 more
- (no location specified)
Jun 20, 2022
COVID-19 Infection, Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor Trial in Seattle (Questionnaire Administration,
Suspended
- COVID-19 Infection
- +2 more
- Questionnaire Administration
- Sotrovimab
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jan 24, 2023
Acquiring Convalescent Specimens for COVID-19 Antibodies
Completed
- COVID-19
- +2 more
- Blood draw
-
New York, New YorkColumbia University Irving Medical Center/NYP
Jul 18, 2022
Coronavirus Infections Trial in Moscow (tixagevimab/cilgavimab 150+150 mg, tixagevimab/cilgavimab 300+300 mg, regdanvimab)
Active, not recruiting
- Coronavirus Infections
- tixagevimab/cilgavimab 150+150 mg
- +2 more
-
Moscow, Russian FederationMoscow City Clinical Hospital 52
Aug 7, 2023
Neuroblastoma, Ganglioneuroblastoma Trial in Moscow (monoclonal antibodies GD2)
Recruiting
- Neuroblastoma
- Ganglioneuroblastoma
- monoclonal antibodies GD2
-
Moscow, Russian FederationResearch Institute of Pediatric Hematology, Oncology and Immunol
Oct 4, 2023
Metastatic Colorectal Carcinoma Trial (Pentoxifylline, FOLFOX, XELOX)
Not yet recruiting
- Metastatic Colorectal Carcinoma
- Pentoxifylline
- +3 more
- (no location specified)
Nov 1, 2023
COVID-19 Trial in Hong Kong (BRII-196 and BRII-198, Placebo)
Withdrawn
- COVID-19
- BRII-196 and BRII-198
- Placebo
-
Hong Kong, ChinaInvestigative Site 1
Mar 1, 2022
Alzheimer Trial in United States (Anti-amyloid Monoclonal Antibodies (mAbs), Standard of Care)
Not yet recruiting
- Alzheimer Disease
- Anti-amyloid Monoclonal Antibodies (mAbs)
- Standard of Care
-
Albany, Georgia
- +7 more
Aug 13, 2023
Monoclonal Antibodies (Sotrovimab )
Recruiting
- COVID-19 Respiratory Infection
-
Dubai, United Arab EmiratesEmirats Health Service
Dec 13, 2021